Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.489. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.489
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →MD Anderson Prostate Cancer SPORE
Grant: P50 CA140388
MD Anderson Prostate Cancer SPORE
Grant: NIH/NCI U01 CA224044
MD Anderson Prostate Cancer SPORE
Grant: CA016672
MD Anderson Prostate Cancer SPORE
Grant: NIH 1S10OD024977-01
NIH HHS
Grant: NIH 1S10OD024977-01 award to the ATGC Core at MD Anderson Cancer Center
NCI NIH HHS
Grant: P30 CA016672
National Institutes of Health
Grant: 5P50CA140388-03
Specimen Core
National Institutes of Health
Grant: 5U01CA224044-05
Patient-Derived Models of Prostate Cancer for Personalized Medicine
National Institutes of Health
Grant: 1S10OD024977-01
NovaSeq6000
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
FWCI
2.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 1 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 2 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 2 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 3 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 3 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 4 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer
Additional file 4 of SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer